These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7669561)

  • 1. Presence of a heterozygous substitution and its relationship to DT-diaphorase activity.
    Kuehl BL; Paterson JW; Peacock JW; Paterson MC; Rauth AM
    Br J Cancer; 1995 Sep; 72(3):555-61. PubMed ID: 7669561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity.
    Traver RD; Horikoshi T; Danenberg KD; Stadlbauer TH; Danenberg PV; Ross D; Gibson NW
    Cancer Res; 1992 Feb; 52(4):797-802. PubMed ID: 1737339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An alternatively spliced form of NQO1 (DT-diaphorase) messenger RNA lacking the putative quinone substrate binding site is present in human normal and tumor tissues.
    Gasdaska PY; Fisher H; Powis G
    Cancer Res; 1995 Jun; 55(12):2542-7. PubMed ID: 7780966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DT-diaphorase activity and mitomycin C sensitivity in non-transformed cell strains derived from members of a cancer-prone family.
    Marshall RS; Paterson MC; Rauth AM
    Carcinogenesis; 1991 Jul; 12(7):1175-80. PubMed ID: 1906377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase).
    Traver RD; Siegel D; Beall HD; Phillips RM; Gibson NW; Franklin WA; Ross D
    Br J Cancer; 1997; 75(1):69-75. PubMed ID: 9000600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the relationship between genotypic status of a DT-diaphorase point mutation and enzymatic activity.
    Misra V; Grondin A; Klamut HJ; Rauth AM
    Br J Cancer; 2000 Oct; 83(8):998-1002. PubMed ID: 10993645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-function studies of DT-diaphorase (NQO1) and NRH: quinone oxidoreductase (NQO2).
    Chen S; Wu K; Knox R
    Free Radic Biol Med; 2000 Aug; 29(3-4):276-84. PubMed ID: 11035256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implication of alternative splicing for expression of a variant NAD(P)H:quinone oxidoreductase-1 with a single nucleotide polymorphism at 465C>T.
    Pan SS; Han Y; Farabaugh P; Xia H
    Pharmacogenetics; 2002 Aug; 12(6):479-88. PubMed ID: 12172217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of NQO1 induction in human tumor cells is not due to changes in the promoter region of the gene.
    Begleiter A; Lange L
    Int J Oncol; 2002 Apr; 20(4):835-8. PubMed ID: 11894133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse NRH:quinone oxidoreductase (NQO2): cloning of cDNA and gene- and tissue-specific expression.
    Long DJ; Jaiswal AK
    Gene; 2000 Jul; 252(1-2):107-17. PubMed ID: 10903442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catalytic properties of NAD(P)H:quinone oxidoreductase-2 (NQO2), a dihydronicotinamide riboside dependent oxidoreductase.
    Wu K; Knox R; Sun XZ; Joseph P; Jaiswal AK; Zhang D; Deng PS; Chen S
    Arch Biochem Biophys; 1997 Nov; 347(2):221-8. PubMed ID: 9367528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfection of COS-1 cells with DT-diaphorase cDNA: role of a base change at position 609.
    Misra V; Klamut HJ; Rauth AM
    Br J Cancer; 1998 Apr; 77(8):1236-40. PubMed ID: 9579828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C609T polymorphism of NAD(P)H quinone oxidoreductase 1 as a predictive biomarker for response to amrubicin.
    Takakuwa O; Oguri T; Ozasa H; Uemura T; Kunii E; Kasai D; Miyazaki M; Maeno K; Sato S
    J Thorac Oncol; 2011 Nov; 6(11):1826-32. PubMed ID: 21964527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular kinetics of induction by oltipraz and its keto derivative of detoxication enzymes in human colon adenocarcinoma cells.
    O'Dwyer PJ; Clayton M; Halbherr T; Myers CB; Yao Ks
    Clin Cancer Res; 1997 May; 3(5):783-91. PubMed ID: 9815750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased levels of NAD(P)H: quinone oxidoreductase 1 (NQO1) in pancreatic tissues from smokers and pancreatic adenocarcinomas: A potential biomarker of early damage in the pancreas.
    Lyn-Cook BD; Yan-Sanders Y; Moore S; Taylor S; Word B; Hammons GJ
    Cell Biol Toxicol; 2006 Mar; 22(2):73-80. PubMed ID: 16532285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of human NAD(P)H: quinone oxidoreductase (DT-diaphorase) in Chinese hamster ovary cells: effect on the toxicity of antitumor quinones.
    Gustafson DL; Beall HD; Bolton EM; Ross D; Waldren CA
    Mol Pharmacol; 1996 Oct; 50(4):728-35. PubMed ID: 8863816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NAD(P)H:quinone oxidoreductase 1 and nrh:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism.
    Jamieson D; Wilson K; Pridgeon S; Margetts JP; Edmondson RJ; Leung HY; Knox R; Boddy AV
    Clin Cancer Res; 2007 Mar; 13(5):1584-90. PubMed ID: 17332305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reductase enzyme expression across the National Cancer Institute Tumor cell line panel: correlation with sensitivity to mitomycin C and EO9.
    Fitzsimmons SA; Workman P; Grever M; Paull K; Camalier R; Lewis AD
    J Natl Cancer Inst; 1996 Mar; 88(5):259-69. PubMed ID: 8614004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by human NAD(P)H quinone oxidoreductase 2: a novel co-substrate-mediated antitumor prodrug therapy.
    Knox RJ; Jenkins TC; Hobbs SM; Chen S; Melton RG; Burke PJ
    Cancer Res; 2000 Aug; 60(15):4179-86. PubMed ID: 10945627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene targeting of DT-diaphorase in mouse embryonic stem cells: establishment of null mutant and its mitomycin C-resistance.
    Yoshida T; Tsuda H
    Biochem Biophys Res Commun; 1995 Sep; 214(2):701-8. PubMed ID: 7677784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.